A1 adenosine receptor agonists and their potential therapeutic applications
E Elzein, J Zablocki - Expert opinion on investigational drugs, 2008 - Taylor & Francis
Background: The challenges in developing any A1 adenosine receptor (A1-AdoR) agonist
involve having the desired effect on target tissue while avoiding side effects due to activation …
involve having the desired effect on target tissue while avoiding side effects due to activation …
Adenosine receptors as drug targets
BB Fredholm - Experimental cell research, 2010 - Elsevier
There are four adenosine receptors, A1, A2A, A2B and A3, together forming a defined
subgroup of G protein coupled receptors. They are well conserved and widely expressed …
subgroup of G protein coupled receptors. They are well conserved and widely expressed …
[HTML][HTML] Adenosine and its receptors as therapeutic targets: an overview
S Sachdeva, M Gupta - Saudi Pharmaceutical Journal, 2013 - Elsevier
The main goal of the authors is to present an overview of adenosine and its receptors, which
are G-protein coupled receptors. The four known adenosine receptor subtypes are …
are G-protein coupled receptors. The four known adenosine receptor subtypes are …
Drugs targeting the A3 adenosine receptor: human clinical study data
P Fishman - Molecules, 2022 - mdpi.com
The A3 adenosine receptor (A3AR) is overexpressed in pathological human cells.
Piclidenoson and namodenoson are A3AR agonists with high affinity and selectivity to …
Piclidenoson and namodenoson are A3AR agonists with high affinity and selectivity to …
Adenosine receptors and their ligands
KN Klotz - Naunyn-Schmiedeberg's archives of pharmacology, 2000 - Springer
The regulatory actions of adenosine are mediated via four subtypes of G protein-coupled
receptors distinguished as A 1, A 2A, A 2B and A 3 receptors. Their presence on basically …
receptors distinguished as A 1, A 2A, A 2B and A 3 receptors. Their presence on basically …
Medicinal chemistry and therapeutic potential of agonists, antagonists and allosteric modulators of A1 adenosine receptor: current status and perspectives
Adenosine is a purine nucleoside, responsible for the regulation of a wide range of
physiological and pathophysiological conditions by binding with four G-protein-coupled …
physiological and pathophysiological conditions by binding with four G-protein-coupled …
Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease
EE Benarroch - Neurology, 2008 - AAN Enterprises
Adenosine is a ubiquitous chemical messenger that modulates cellular activity in both the
CNS and peripheral organs. 1-5 Adenosine levels in the brain extracellular space increase …
CNS and peripheral organs. 1-5 Adenosine levels in the brain extracellular space increase …
[HTML][HTML] Adenosine receptors and cancer
Adenosine is a ubiquitous signaling molecule whose physiological functions are mediated
by its interaction with four G-protein-coupled receptor subtypes, termed A1, A2A, A2B and …
by its interaction with four G-protein-coupled receptor subtypes, termed A1, A2A, A2B and …
History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents
D Preti, PG Baraldi, AR Moorman… - Medicinal research …, 2015 - Wiley Online Library
Growing evidence emphasizes that the purine nucleoside adenosine plays an active role as
a local regulator in different pathologies. Adenosine is a ubiquitous nucleoside involved in …
a local regulator in different pathologies. Adenosine is a ubiquitous nucleoside involved in …
Adenosine receptor ligands-recent developments part I. Agonists
CE Muller - Current medicinal chemistry, 2000 - ingentaconnect.com
Developments in the field of adenosine receptor (AR) agonists of the past years are
presented and discussed. Four different AR subtypes, A1, A2A, A2B, and A3, have been …
presented and discussed. Four different AR subtypes, A1, A2A, A2B, and A3, have been …